Unternehmen Unichem Laboratories Limited NSE India S.E.
Aktien
A1C7Z4
INE351A01035
UNICHEMLAB
Pharmazeutika
Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
558.7 INR | -0.09% | -0.89% | +37.77% |
Kurzporträt
Mitarbeiterzahl: 2 894
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Formulations
86,2
%
| 10 969 | 86,4 % | 11 582 | 86,2 % | +5.60% |
Bulk Drugs and Chemicals
10,7
%
| 1 511 | 11,9 % | 1 442 | 10,7 % | -4.59% |
Other
1,7
%
| 119 | 0,9 % | 230 | 1,7 % | +93.92% |
Export Benefits
1,3
%
| 100 | 0,8 % | 176 | 1,3 % | +76.18% |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
60,3
%
| 7 343 | 58,8 % | 7 856 | 60,3 % | +6.98% |
Others
37,2
%
| 4 724 | 37,9 % | 4 846 | 37,2 % | +2.58% |
India
2,5
%
| 413 | 3,3 % | 322 | 2,5 % | -21.92% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 55 | 10.08.23 | |
Sandip Ghume
DFI | Director of Finance/CFO | - | 30.10.18 |
Chairman | 71 | 21.08.77 | |
Pradeep Bhandari
CMP | Compliance Officer | - | 01.08.19 |
Dilip Bhor
IRO | Public Communications Contact | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Pranay Godha
BRD | Director/Board Member | 51 | 10.08.23 |
Director/Board Member | 75 | - | |
Chairman | 71 | 21.08.77 | |
Director/Board Member | 66 | - | |
Chief Executive Officer | 55 | 10.08.23 | |
Priti Puri
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 70 405 750 | 20 283 296 ( 28,81 %) | 0 | 28,81 % |
Unternehmenskontakt
Unichem Laboratories Ltd.
Unichem Bhavan Prabhat Estate, Off. S.V. Road
400102, Mumbai
+91 22 6688 8333
http://www.unichemlabs.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Niche Generics Ltd.
Niche Generics Ltd. Medical DistributorsDistribution Services Niche Generics Ltd. marketed and distributed pharmaceutical products. It offered antifungal, antineoplastic, antispasmodic/anticholinergic, cardiovascular system, and central nervous system, as well as pain, analgesic, and antipyretic products. The firm products are supplied via wholesalers in the United Kingdom; sales in Europe; and selected partners to other territories. The company was founded on January 15, 2002 and was headquartered in Hitchin, the United Kingdom. |
Medical Distributors
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
+29.98% | 684 Mrd. | |
+30.34% | 568 Mrd. | |
-3.52% | 361 Mrd. | |
+18.59% | 329 Mrd. | |
+4.07% | 284 Mrd. | |
+16.21% | 240 Mrd. | |
+9.66% | 208 Mrd. | |
-6.83% | 200 Mrd. | |
+7.09% | 166 Mrd. |
- Börse
- Aktien
- A1C7Z4 Aktie
- A1C7Z4 Aktie
- Unternehmen Unichem Laboratories Limited